Viberzi — United Healthcare
irritable bowel syndrome with diarrhea (IBS-D)
Initial criteria
- Diagnosis of irritable bowel syndrome with diarrhea (IBS-D)
- History of failure, contraindication or intolerance to a tricyclic antidepressant (e.g., amitriptyline)
Reauthorization criteria
- Documentation of positive clinical response to Viberzi therapy
Approval duration
12 months